Thrombin generation in vitro and in vivo, and disturbed tissue factor regulation in patients with acute pancreatitis

Pancreatology

Volumn 11, Issue 6, 2011, Pages 557-566

  Lindström, Outi K ^a   Tukiainen, Eija M ^a   Kylänpää, Marja Leena ^a   Mentula, Panu J ^a   Puolakkainen, Pauli A ^a   Wartiovaara Kautto, Ulla M K ^a   Repo, Heikki ^b   Petäjä, Jari M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Acute pancreatitis; Organ failure; Prothrombin fragment; Thrombogram; Tissue factor; Tissue factor pathway inhibitor

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRINOGEN; PROTEIN C; PROTHROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PARTIAL THROMBOPLASTIN TIME; PLASMA; PRIORITY JOURNAL; PROTHROMBIN TIME; REGULATORY MECHANISM; THROMBIN TIME; THROMBOCYTE COUNT;

EID: 84855170025     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000333481     Document Type: Article

References (44)

1. Steinberg W, Tenner S: Acute pancreatitis. N Engl J Med 1994; 330: 1198-1210. (Pubitemid 24984692)
2. Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, Banks PA: Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997; 113: 899-903. (Pubitemid 27381150)
3. Mentula P, Kylanpaa ML, Kemppainen E, Jansson SE, Sarna S, Puolakkainen P, Haapiainen R, Repo H: Early prediction of organ failure by combined markers in patients with acute pancreatitis. Br J Surg 2005; 92: 68-75. (Pubitemid 40144197)
4. Repo H, Harlan JM: Mechanisms and consequences of phagocyte adhesion to endothelium. Ann Med 1999; 31: 156-165. (Pubitemid 29304453)
5. Neoptolemos JP, Raraty M, Finch M, Sutton R: Acute pancreatitis: The substantial human and financial costs. Gut 1998; 42: 886-891. (Pubitemid 28277235)
6. Cuthbertson CM, Christophi C: Disturbances of the microcirculation in acute pancreatitis. Br J Surg 2006; 93: 518-530.
7. Levi M, van der Poll T, ten Cate H: Tissue factor in infection and severe inflammation. Semin Thromb Hemost 2006; 32: 33-39.
8. Gando S, Nanzaki S, Sasaki S, Kemmotsu O: Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost 1998; 79: 1111-1115. (Pubitemid 28297156)
9. Gando S, Kameue T, Matsuda N, Hayakawa M, Morimoto Y, Ishitani T, Kemmotsu O: Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Thromb Res 2003; 109: 119-124. (Pubitemid 36428762)
10. Gando S, Kameue T, Morimoto Y, Matsuda N, Hayakawa M, Kemmotsu O: Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis. Crit Care Med 2002; 30: 1729-1734. (Pubitemid 34879582)
11. Sawa H, Ueda T, Takeyama Y, Yasuda T, Matsumura N, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y: Elevation of plasma tissue factor levels in patients with severe acute pancreatitis. J Gastroenterol 2006; 41: 575-581. (Pubitemid 44138200)
12. Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr: Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 1988; 72: 2020-2025. (Pubitemid 19030892)
13. Sidelmann JJ, Bladbjerg EM, Gram J, Munster AM, Jespersen J: Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis. Blood Coagul Fibrinolysis 2008; 19: 405-409.
14. Abdel Gader AM, Al-Mishari AA, Awadalla SA, Buyuomi NM, Khashoggi T, Al-Hakeem M: Total and free tissue factor pathway inhibitor in pregnancy hypertension. Int J Gynaecol Obstet 2006; 95: 248-253. (Pubitemid 44715902)
15. Brodin E, Borvik T, Sandset PM, Bonaa KH, Nordoy A, Hansen JB: Coagulation activation in young survivors of myocardial infarction (MI) -a population-based casecontrol study. Thromb Haemost 2004; 92: 178-184. (Pubitemid 39010881)
16. Ota S, Wada H, Abe Y, Yamada E, Sakaguchi A, Nishioka J, Hatada T, Ishikura K, Yamada N, Sudo A, Uchida A, Nobori T: Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis. Clin Appl Thromb Hemost 2008; 14: 279-285. (Pubitemid 351871950)
17. van der Poll T, Buller HR, ten Cate H, Wortel CH, Bauer KA, van Deventer SJ, Hack CE, Sauerwein HP, Rosenberg RD, ten Cate JW: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322: 1622-1627. (Pubitemid 20171585)
18. MacCallum PK, Thomson JM, Poller L: Effects of fixed minidose warfarin on coagulation and fibrinolysis following major gynaecological surgery. Thromb Haemost 1990; 64: 511-515.
19. Teitel JM, Bauer KA, Lau HK, Rosenberg RD: Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/ F1 + 2 fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086-1097. (Pubitemid 12125604)
20. Pelzer H, Schwarz A, Stuber W: Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991; 65: 153-159.
21. Hemker HC, Beguin S: Phenotyping the clotting system. Thromb Haemost 2000; 84: 747-751.
22. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC: The thrombogram in rare inherited coagulation disorders: Its relation to clinical bleeding. Thromb Haemost 2002; 88: 576-582. (Pubitemid 35173997)
23. Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590.
24. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH): Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327-1330. (Pubitemid 33064585)
25. Warshawsky I, Bu G, Mast A, Saffitz JE, Broze GJ Jr, Schwartz AL: The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo. J Clin Invest 1995; 95: 1773-1781.
26. Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Beguin S: The thrombogram: Monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000; 83: 589-591. (Pubitemid 30201136)
27. Hemker HC, Al Dieri R, De Smedt E, Beguin S: Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 2006; 96: 553-561. (Pubitemid 44782533)
28. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S: The calibrated automated thrombogram (CAT): A universal routine test for hyper-and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-253. (Pubitemid 37490547)
29. Lasson A, Ohlsson K: Disseminated intravascular coagulation and antiprotease activity in acute human pancreatitis. Scand J Gastroenterol Suppl 1986; 126: 35-39. (Pubitemid 17216609)
30. Lasson A, Ohlsson K: Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. Thromb Res 1986; 41: 167-183. (Pubitemid 16165692)
31. Maeda K, Hirota M, Ichihara A, Ohmuraya M, Hashimoto D, Sugita H, Takamori H, Kanemitsu K, Baba H: Applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis. Pancreas 2006; 32: 87-92. (Pubitemid 41803652)
32. Salomone T, Tosi P, Palareti G, Tomassetti P, Migliori M, Guariento A, Saieva C, Raiti C, Romboli M, Gullo L: Coagulative disorders in human acute pancreatitis: Role for the Ddimer. Pancreas 2003; 26: 111-116. (Pubitemid 36278294)
33. Radenkovic DV, Bajec DD, Karamarkovic AR: Discussion on applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis. Pancreas 2006; 33: 106-107. (Pubitemid 43995349)
34. Radenkovic D, Bajec D, Karamarkovic A, Stefanovic B, Milic N, Ignjatovic S, Gregoric P, Milicevic M: Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis. Pancreas 2004; 29: 152-156. (Pubitemid 38971805)
35. Yasuda T, Ueda T, Kamei K, Shinzaki W, Sawa H, Shinzeki M, Ku Y, Takeyama Y: Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis. J Gastroenterol 2009; 44: 1071-1079.
36. Sidelmann JJ, Bladbjerg EM, Gram J, Munster AM, Jespersen J: Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis. Blood Coagul Fibrinolysis 2008; 19: 405-409.
37. Lwaleed BA, Bass PS: Tissue factor pathway inhibitor: Structure, biology and involvement in disease. J Pathol 2006; 208: 327-339. (Pubitemid 43210519)
38. Lindahl AK, Sandset PM, Abildgaard U: The present status of tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 1992; 3: 439-449.
39. Broze GJ Jr, Lange GW, Duffin KL, MacPhail L: Heterogeneity of plasma tissue factor pathway inhibitor. Blood Coagul Fibrinolysis 1994; 5: 551-559. (Pubitemid 24301576)
40. Petersen LC, Bjorn SE, Nordfang O: Effect of leukocyte proteinases on tissue factor pathway inhibitor. Thromb Haemost 1992; 67: 537-541.
41. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr; Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699-709.
42. Lindstrom O, Kylanpaa L, Mentula P, Puolakkainen P, Kemppainen E, Haapiainen R, Fernandez JA, Griffin JH, Repo H, Petaja J: Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis. Crit Care 2006; 10:R16.
43. Esmon CT: Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Baillieres Best Pract Res Clin Haematol 1999; 12: 343-359. (Pubitemid 30312615)
44. Esmon CT: Crosstalk between inflammation and thrombosis. Maturitas 2004; 47: 305-314. (Pubitemid 38520117)